320
Participants
Start Date
February 1, 2022
Primary Completion Date
July 31, 2028
Study Completion Date
July 31, 2028
Mosunetuzumab (Cohorts A-C)
Participants will receive SC mosunetuzumab for up to 17 cycles and for optional maintenance (Cohort A only)
Mosunetuzumab (Cohorts D-E)
Participants will receive SC mosunetuzumab for up to 34 cycles
Tocilizumab
Participants can be treated with tocilizumab if they present with CRS after receiving mosunetuzumab
North Shore Hematology Oncology Association PC, Shirley
New York Oncology Hematology, P.C., Albany
McGlinn Cancer Institute at Reading Hospital, West Reading
Tennessee Oncology Chattanooga, Alexandria
SCRI Florida Cancer Specialists South, Fort Myers
Tennessee Oncology - Nashville, Nashville
Mayo Clinic - PPDS, Rochester
St. Vincent Frontier Cancer Center, Billings
University of Kansas Medical Center, Westwood
Hematology Oncology Clinic, Baton Rouge
Texas Oncology-Austin Midtown, Austin
San Juan Oncology Associates, Farmington
City of Hope, Duarte
Oncology Associates of Oregon, P.C., Eugene
Alaska Oncology & Hematology, LLC, Anchorage
Infirmary Cancer Care, Mobile
Mayo Clinic Arizona, Phoenix
Rocky Mountain Cancer Centers (Aurora) - USOR, Aurora
Medical Oncology Hematology Consultants, Newark
Mayo Clinic Jacksonville - PPDS, Jacksonville
Cancer Specialists of North Florida (AC Skinner Bldg 100), Jacksonville
Florida Cancer Specialists - NORTH - SCRI - PPDS, St. Petersburg
Florida Cancer Specialists - EAST - SCRI - PPDS, West Palm Beach
Mission Blood and Cancer - MercyOne Cancer Center, Des Moines
American Oncology Partners of Maryland, PA, Bethesda
Astera Cancer Care East Brunswick, East Brunswick
New York Cancer & Blood Specialists - New Hyde Park, New Hyde Park
NY Cancer & Blood Specialist, New York
New York Cancer & Blood Specialists - Bronx, The Bronx
Oncology Hematology Care Inc - Cincinnati - USOR, Cincinnati
Providence Cancer Institute, Portland
Kaiser Foundation Hospitals, Portland
Texas Oncology (Amarillo) - USOR - 1826 Point West Pkwy, Amarillo
Texas Oncology (Worth) - USOR, Dallas
Texas Oncology (Tyler) - USOR, Tyler
Virginia Cancer Specialists - Gainsville, Gainesville
Kadlec Clinic Hematology and Oncology, Kennewick
VA Puget Sound Health Care System - NAVREF - PPDS, Seattle
MultiCare Deaconess Cancer and Blood Specialty Center, Spokane
Lead Sponsor
Genentech, Inc.
INDUSTRY